CleanNA

CleanNA

Pre-clinical
Waddinxveen, NetherlandsFounded 2010cleanna.com

CleanNA, founded in 2010 and spun off as a separate entity within the Double Helix Group in 2019, develops and manufactures proprietary magnetic bead-based reagents for automated DNA and RNA extraction. The company serves both research and diagnostic markets with products certified under an EN-ISO 13485 Quality Management System. Its mission is to support laboratories by reducing hands-on time and improving yield and quality for demanding downstream applications like NGS, CRISPR, and qPCR.

Founded
2010

AI Company Overview

CleanNA, founded in 2010 and spun off as a separate entity within the Double Helix Group in 2019, develops and manufactures proprietary magnetic bead-based reagents for automated DNA and RNA extraction. The company serves both research and diagnostic markets with products certified under an EN-ISO 13485 Quality Management System. Its mission is to support laboratories by reducing hands-on time and improving yield and quality for demanding downstream applications like NGS, CRISPR, and qPCR.

Technology Platform

Proprietary magnetic bead-based chemistry for the automated isolation and purification of DNA and RNA from diverse sample types, optimized for integration with laboratory automation systems.

Opportunities

Growth is driven by increasing laboratory automation, expansion of NGS and molecular diagnostics, and the need for specialized solutions for challenging sample types.
Participation in niche events like CropIB 2026 highlights opportunities in plant genomics and agricultural research.

Risk Factors

Key risks include intense competition from large multinational reagent suppliers, dependence on the Double Helix Group, supply chain vulnerabilities for raw materials, and the ongoing cost and complexity of maintaining regulatory certifications for IVD products.

Competitive Landscape

Competes against giants like Qiagen, Thermo Fisher, and Promega by specializing in automation-friendly, magnetic bead-based reagents and targeting niche applications with challenging samples. Differentiates on value-for-money and direct replacement of established products like AMPureXP beads.

Company Info

TypeDiagnostics
Founded2010
LocationWaddinxveen, Netherlands
StagePre-clinical
RevenueRevenue Generating

Therapeutic Areas

GenomicsMolecular Diagnostics

Partners

GC biotech (historical incubator)
SIMILAR COMPANIES
2-BBB Medicines
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile